ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $466,860 | +24.2% | 8,041 | +15.2% | 0.00% | +50.0% |
| Q2 2023 | $375,841 | +36.6% | 6,982 | +0.8% | 0.00% | 0.0% |
| Q1 2023 | $275,061 | -0.8% | 6,925 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $277,185 | +25.4% | 6,890 | +0.4% | 0.00% | 0.0% |
| Q3 2022 | $221,000 | +8.3% | 6,865 | -0.0% | 0.00% | +100.0% |
| Q2 2022 | $204,000 | +13.3% | 6,866 | +7.2% | 0.00% | 0.0% |
| Q1 2022 | $180,000 | -41.2% | 6,405 | -3.6% | 0.00% | -50.0% |
| Q4 2021 | $306,000 | +52.2% | 6,644 | +8.4% | 0.00% | +100.0% |
| Q3 2021 | $201,000 | -9.9% | 6,130 | -3.7% | 0.00% | 0.0% |
| Q2 2021 | $223,000 | -1.8% | 6,364 | +1.3% | 0.00% | 0.0% |
| Q1 2021 | $227,000 | +22.7% | 6,284 | -1.2% | 0.00% | 0.0% |
| Q4 2020 | $185,000 | +0.5% | 6,358 | -2.4% | 0.00% | 0.0% |
| Q3 2020 | $184,000 | -14.4% | 6,513 | -2.3% | 0.00% | 0.0% |
| Q2 2020 | $215,000 | -16.3% | 6,663 | +5.7% | 0.00% | 0.0% |
| Q1 2020 | $257,000 | -37.0% | 6,302 | -4.7% | 0.00% | -50.0% |
| Q4 2019 | $408,000 | -17.6% | 6,614 | -2.6% | 0.00% | 0.0% |
| Q3 2019 | $495,000 | -11.1% | 6,793 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $557,000 | +30.1% | 6,772 | +11.5% | 0.00% | 0.0% |
| Q1 2019 | $428,000 | +52.3% | 6,072 | -2.6% | 0.00% | +100.0% |
| Q4 2018 | $281,000 | -21.3% | 6,235 | -1.1% | 0.00% | 0.0% |
| Q3 2018 | $357,000 | -15.0% | 6,307 | +0.4% | 0.00% | 0.0% |
| Q2 2018 | $420,000 | +40.5% | 6,283 | +22.5% | 0.00% | 0.0% |
| Q1 2018 | $299,000 | -28.5% | 5,129 | -21.0% | 0.00% | 0.0% |
| Q4 2017 | $418,000 | +23.3% | 6,492 | +0.4% | 0.00% | 0.0% |
| Q3 2017 | $339,000 | +20.6% | 6,467 | +7.6% | 0.00% | 0.0% |
| Q2 2017 | $281,000 | +16.1% | 6,009 | +23.1% | 0.00% | 0.0% |
| Q1 2017 | $242,000 | -31.4% | 4,881 | -16.1% | 0.00% | 0.0% |
| Q4 2016 | $353,000 | -99.9% | 5,817 | -1.3% | 0.00% | -50.0% |
| Q3 2016 | $391,133,000 | +20.0% | 5,895 | +1.0% | 0.00% | +100.0% |
| Q2 2016 | $325,933,000 | +64.6% | 5,839 | -0.8% | 0.00% | 0.0% |
| Q1 2016 | $198,000,000 | -22.0% | 5,889 | +4.5% | 0.00% | 0.0% |
| Q4 2015 | $254,000,000 | +111303.5% | 5,634 | -2.4% | 0.00% | 0.0% |
| Q3 2015 | $228,000 | -99.9% | 5,772 | -0.8% | 0.00% | 0.0% |
| Q2 2015 | $361,193,000 | +1.3% | 5,821 | +2.1% | 0.00% | 0.0% |
| Q1 2015 | $356,472,000 | +40.4% | 5,699 | +26.5% | 0.00% | 0.0% |
| Q4 2014 | $253,980,000 | +99.8% | 4,504 | +0.2% | 0.00% | 0.0% |
| Q3 2014 | $127,090,000 | -18.0% | 4,494 | -0.1% | 0.00% | 0.0% |
| Q2 2014 | $154,911,000 | – | 4,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 328,494 | $15,137,000 | 4.72% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $13,824,000 | 2.78% |
| Mesirow Financial Investment Management, Inc. | 12,277 | $566,000 | 1.63% |
| Parkman Healthcare Partners LLC | 137,226 | $6,323,000 | 1.40% |
| Global Alpha Capital Management Ltd. | 284,831 | $13,125,000 | 1.27% |
| Stonepine Capital Management, LLC | 52,290 | $2,410,000 | 1.11% |
| 1492 Capital Management LLC | 43,611 | $2,010,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,770 | $3,445,000 | 0.81% |
| Walthausen & Co., LLC | 61,456 | $2,832,000 | 0.74% |
| Rubric Capital Management LP | 307,557 | $14,172,000 | 0.67% |